Charles Schwab’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7M | Buy |
314,627
+53,384
| +20% | +$3.68M | ﹤0.01% | 1626 |
|
|
2025
Q1 | $18.1M | Buy |
261,243
+35,329
| +16% | +$2.45M | ﹤0.01% | 1687 |
|
|
2024
Q4 | $19.4M | Buy |
225,914
+21,331
| +10% | +$1.83M | ﹤0.01% | 1714 |
|
|
2024
Q3 | $24.4M | Buy |
204,583
+28,988
| +17% | +$3.45M | ﹤0.01% | 1586 |
|
|
2024
Q2 | $25.1M | Buy |
175,595
+47,526
| +37% | +$6.78M | ﹤0.01% | 1521 |
|
|
2024
Q1 | $16.4M | Buy |
128,069
+33,525
| +35% | +$4.3M | ﹤0.01% | 1717 |
|
|
2023
Q4 | $9.78M | Buy |
94,544
+26,067
| +38% | +$2.7M | ﹤0.01% | 1999 |
|
|
2023
Q3 | $6.23M | Buy |
68,477
+28,879
| +73% | +$2.63M | ﹤0.01% | 2150 |
|
|
2023
Q2 | $3.2M | Buy |
39,598
+16,424
| +71% | +$1.33M | ﹤0.01% | 2401 |
|
|
2023
Q1 | $1.84M | Buy |
23,174
+9,828
| +74% | +$782K | ﹤0.01% | 2547 |
|
|
2022
Q4 | $903K | Buy |
+13,346
| New | +$903K | ﹤0.01% | 2804 |
|
|
2021
Q3 | – | Sell |
-88,934
| Closed | -$3.73M | – | 3533 |
|
|
2021
Q2 | $3.73M | Sell |
88,934
-128,686
| -59% | -$5.39M | ﹤0.01% | 2488 |
|
|
2021
Q1 | $7.34M | Sell |
217,620
-132,624
| -38% | -$4.47M | ﹤0.01% | 2110 |
|
|
2020
Q4 | $12.2M | Buy |
350,244
+118,048
| +51% | +$4.12M | ﹤0.01% | 1741 |
|
|
2020
Q3 | $8.06M | Buy |
232,196
+193,612
| +502% | +$6.72M | ﹤0.01% | 1826 |
|
|
2020
Q2 | $1.26M | Sell |
38,584
-82,886
| -68% | -$2.72M | ﹤0.01% | 2560 |
|
|
2020
Q1 | $3.66M | Sell |
121,470
-3,816
| -3% | -$115K | ﹤0.01% | 1990 |
|
|
2019
Q4 | $3.63M | Sell |
125,286
-134,690
| -52% | -$3.9M | ﹤0.01% | 2187 |
|
|
2019
Q3 | $6.72M | Sell |
259,976
-335,094
| -56% | -$8.66M | ﹤0.01% | 1822 |
|
|
2019
Q2 | $15.2M | Buy |
+595,070
| New | +$15.2M | 0.01% | 1327 |
|